ArticleTranslational research : the journal of laboratory and clinical medicine2018

Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline.

Ari W Schaler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.